The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study.Mirjam A. G. Sprangers, Neil K. Aaronson, Hanneke C. de Haes et al.|Journal of Clinical Oncology|1996Cited by 1.2k
The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognosesHelen Campbell, Mark Sculpher, David Epstein et al.|European Journal of Cancer|2011Cited by 46
Impact on quality of life (QL) during chemotherapy (CT) of FEC-T compared to FEC or E-CMF: Results from the UK NCRI Taxotere as Adjuvant Chemotherapy Trial (TACT)Penelope Hopwood, David Cameron, Peter Ellis et al.|Journal of Clinical Oncology|2005Cited by 7
Impact on quality of life (QoL) of FEC-T compared with FEC or E-CMF: UK Taxotere as Adjuvant Chemotherapy Trial (TACT) 2-year follow-upPenelope Hopwood, David Cameron, Antonia Ridolfi et al.|Journal of Clinical Oncology|2008Cited by 3